Clinical Trials Logo
  1. Home
  2. Adenovirus
  3. NCT00448994

Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients

Adenovirus Clinical Trial

Official title:
Serial Monitoring of Adenovirus and Fungal Load by Real-Time, Quantitative Polymerase Chain Reaction (PCR) Assay and Correlation With Outcomes in Pediatric Hematopoietic Stem Cell Transplant Patients

Clinical Trial Summary

This study is designed to determine the rate at which stem cell transplant patients can develop infection caused by a group of viruses, known as adenovirus, and common fungi. Stem cells are unspecialized cells, capable of producing more stem cells or other specialized cells, and are used to replace damaged or diseased cells. The study will be conducted in children (2-17years old) being transplanted with stem cells from a donor. Patients undergoing stem cell transplantation are more likely to develop infections as their immune systems are weakened. Blood, stool, urine and throat swab samples will be collected (for at least 100 days on a weekly basis) to detect infection(s) caused by adenovirus or fungus. Subjects will participate for up to 1 year following the transplant procedure.

Clinical Trial Description

This study is a multi-center observational study to determine the usefulness of real time PCR in the detection of adenovirus and fungal infections in patients following HSCT. Quantitative viral load monitoring will be evaluated to establish correlation with clinical symptoms and to measure the effectiveness of the therapeutic interventions. Samples will be collected prior to HSCT and on a scheduled weekly basis for 100 days post-HSCT and after that when patients show signs of infection. Patients' signs and symptoms and outcomes will be recorded for correlation with viral load. In addition, viral cultures will be performed on the same schedule as PCR assay using 3 samples (throat swab, stool, and urine). The study will be conducted at approximately 6 centers in the United States. ;

Study Design

Observational Model: Case-Only

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00448994
Study type Observational
Source ViraCor Laboratories
Contact
Status Withdrawn
Phase N/A
Start date March 2007
Completion date July 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT02984280 - Specific Respiratory Infections as Triggers of Acute Medical Events N/A
Recruiting NCT03665675 - Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT Early Phase 1
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Recruiting NCT03266627 - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection Phase 2
Not yet recruiting NCT03325517 - Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics N/A
Not yet recruiting NCT06392451 - LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia N/A
Recruiting NCT05183490 - R-MVST Cells for Treatment of Viral Infections Phase 1
Completed NCT04056546 - Interest of Rapid Typing in Adenovirus Infections.
Recruiting NCT06299813 - Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection Phase 3
Enrolling by invitation NCT06027879 - Anti-viral T-cell Therapy by Gamma Capture Phase 1/Phase 2
Recruiting NCT02779439 - Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation Phase 1
Terminated NCT02420080 - A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304 N/A
Active, not recruiting NCT01945814 - Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) Phase 1
Completed NCT01535885 - Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV Phase 1
Terminated NCT03339401 - The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation Phase 2
Withdrawn NCT01584037 - Adenovirus Vaccine Pregnancy Registry N/A
Withdrawn NCT03532035 - Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia Phase 2
Recruiting NCT02008812 - Ad Sensor-based Real-time Diagnosis of Adenovirus N/A
Active, not recruiting NCT04364178 - Viral Specific T-Lymphocytes to Treat Adenovirus or CMV Phase 1/Phase 2
Recruiting NCT05664126 - Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation Phase 2